Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease (Q39675706)
Jump to navigation
Jump to search
scientific article published on 21 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease |
scientific article published on 21 July 2010 |
Statements
1 reference
Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease (English)
1 reference
1 reference
Matthew J Walters
1 reference
Yu Wang
1 reference
Nu Lai
1 reference
Trageen Baumgart
1 reference
Bin N Zhao
1 reference
Daniel J Dairaghi
1 reference
Pirow Bekker
1 reference
Linda S Ertl
1 reference
Mark E T Penfold
1 reference
Juan C Jaen
1 reference
Emily Wendt
1 reference
Andrew Pennell
1 reference
Solomon Ungashe
1 reference
Zheng Wei
1 reference
J J Kim Wright
1 reference
Thomas J Schall
1 reference
21 July 2010
1 reference
1 reference
Identifiers
1 reference